Product Code: ETC018345 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Thailand pharmaceuticals and chemical market is expected to register a CAGR of 5.1% during the forecast period (2020-2026). The country has an increasing number of medical centers, hospitals, and clinics due to the expanding healthcare infrastructure in the region. In addition, rising government support for foreign investments in the industry along with expansion strategies adopted by international players into Thailand are driving growth in this market.
Thailand pharmaceutical industry is expected to be driven by a number of factors such as increasing public health expenditure, rising domestic demand for medicines and medical devices, improving regulatory framework, and growing economic development. Furthermore, the government`s focus on establishing healthcare infrastructure in rural areas has attracted investments from major global players. Additionally, an increase in the number of clinical trials conducted by international companies has further contributed to the growth of this industry.
Poor intellectual property rights protection can limit innovation as companies may be less likely to make substantial investments if their profits cannot be secured through patenting or licensing practices thus restricting revenues earned from drug sales within Thailand jurisdiction thereby challenging potential economic growth opportunities available here.
The outbreak of Covid-19 pandemic has adversely impacted all industries globally including those related to pharmaceuticals & chemicals due to restrictions imposed by governments across countries leading towards reduced production volumes & exports resulting into decreased revenues derived from them while posing serious challenges ahead as far as recovery efforts are concerned post crisis situation eventually affecting overall performance trajectory of this market over near future time frame till 2026 conclusion year end date becomes apparent at present timescales .
Some key players operating within Thailand Pharmaceuticals & Chemical Market include Pfizer Inc., Novartis AG, Sanofi S A., Merck KGaA,Bayer Aktiengesellschaft, Johnson&Johnson Services Inc., GlaxoSmithKline Plc, Solvay SA, Daiichi Sankyo Company Limited, SK Holdings Co Ltd etc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand pharmaceuticals chemical Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand pharmaceuticals chemical Market Revenues & Volume, 2020 & 2030F |
3.3 Thailand pharmaceuticals chemical Market - Industry Life Cycle |
3.4 Thailand pharmaceuticals chemical Market - Porter's Five Forces |
3.5 Thailand pharmaceuticals chemical Market Revenues & Volume Share, By Type, 2020 & 2030F |
3.6 Thailand pharmaceuticals chemical Market Revenues & Volume Share, By Application, 2020 & 2030F |
3.7 Thailand pharmaceuticals chemical Market Revenues & Volume Share, By Sales Channel, 2020 & 2030F |
4 Thailand pharmaceuticals chemical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand pharmaceuticals chemical Market Trends |
6 Thailand pharmaceuticals chemical Market, By Types |
6.1 Thailand pharmaceuticals chemical Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand pharmaceuticals chemical Market Revenues & Volume, By Type, 2020-2030F |
6.1.3 Thailand pharmaceuticals chemical Market Revenues & Volume, By Basic building blocks , 2020-2030F |
6.1.4 Thailand pharmaceuticals chemical Market Revenues & Volume, By Advanced intermediates , 2020-2030F |
6.1.5 Thailand pharmaceuticals chemical Market Revenues & Volume, By Active ingredients, 2020-2030F |
6.2 Thailand pharmaceuticals chemical Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand pharmaceuticals chemical Market Revenues & Volume, By Cardiovascular , 2020-2030F |
6.2.3 Thailand pharmaceuticals chemical Market Revenues & Volume, By Neurology , 2020-2030F |
6.2.4 Thailand pharmaceuticals chemical Market Revenues & Volume, By Oncology , 2020-2030F |
6.2.5 Thailand pharmaceuticals chemical Market Revenues & Volume, By Infectious diseases, 2020-2030F |
6.2.6 Thailand pharmaceuticals chemical Market Revenues & Volume, By Metabolic system , 2020-2030F |
6.2.7 Thailand pharmaceuticals chemical Market Revenues & Volume, By Diabetes , 2020-2030F |
6.2.8 Thailand pharmaceuticals chemical Market Revenues & Volume, By Other, 2020-2030F |
6.2.9 Thailand pharmaceuticals chemical Market Revenues & Volume, By Other, 2020-2030F |
6.3 Thailand pharmaceuticals chemical Market, By Sales Channel |
6.3.1 Overview and Analysis |
6.3.2 Thailand pharmaceuticals chemical Market Revenues & Volume, By Offline, 2020-2030F |
6.3.3 Thailand pharmaceuticals chemical Market Revenues & Volume, By Online, 2020-2030F |
7 Thailand pharmaceuticals chemical Market Import-Export Trade Statistics |
7.1 Thailand pharmaceuticals chemical Market Export to Major Countries |
7.2 Thailand pharmaceuticals chemical Market Imports from Major Countries |
8 Thailand pharmaceuticals chemical Market Key Performance Indicators |
9 Thailand pharmaceuticals chemical Market - Opportunity Assessment |
9.1 Thailand pharmaceuticals chemical Market Opportunity Assessment, By Type, 2020 & 2030F |
9.2 Thailand pharmaceuticals chemical Market Opportunity Assessment, By Application, 2020 & 2030F |
9.3 Thailand pharmaceuticals chemical Market Opportunity Assessment, By Sales Channel, 2020 & 2030F |
10 Thailand pharmaceuticals chemical Market - Competitive Landscape |
10.1 Thailand pharmaceuticals chemical Market Revenue Share, By Companies, 2023 |
10.2 Thailand pharmaceuticals chemical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |